Understanding breast cancer in remission, breast cancer history, and post-treatment breast cancer is crucial for accurate healthcare documentation and medical coding. This resource provides information on clinical terms, diagnosis codes, and best practices for documenting breast cancer in remission in patient charts and medical records. Learn about follow-up care, surveillance, and long-term health management for individuals with a history of breast cancer. This information is vital for physicians, nurses, medical coders, and other healthcare professionals involved in the care of patients with a previous breast cancer diagnosis.
Also known as
Personal history of malignant neoplasm of breast
History of breast cancer, now in remission or post-treatment.
Malignant neoplasm of breast
Used for active breast cancer, may be relevant for specifying original diagnosis.
Factors influencing health status and contact with health services
Encompasses follow-up exams and aftercare related to a history of breast cancer.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the breast cancer currently active?
When to use each related code
| Description |
|---|
| Breast cancer previously treated, now without signs of disease. |
| Active breast cancer with or without distant spread. |
| Abnormal breast cells with increased risk of becoming cancerous. |
Inaccurate coding of remission status (active vs. history) can impact reimbursement and quality metrics. Use Z85.3.
Documenting 'history of' without specifying type (e.g., ductal) may lead to undercoding and lost revenue. CDI query needed.
Missing laterality (left, right, bilateral) for the primary breast cancer impacts staging and treatment data. Clarify with physician.
Q: What are the most effective strategies for long-term surveillance and recurrence monitoring in patients with breast cancer in remission, considering both clinical and imaging modalities?
A: Developing a personalized long-term surveillance plan for patients with breast cancer in remission requires careful consideration of individual risk factors, including initial stage, hormone receptor status, and HER2 status. Clinical breast exams remain crucial, typically performed every 3-6 months for the first 5 years, then annually. Mammography is recommended annually, with consideration for supplemental imaging like breast MRI for high-risk patients. Explore how incorporating circulating tumor DNA (ctDNA) analysis and other emerging biomarkers can enhance early detection of recurrence. Consider implementing risk-stratified surveillance protocols to optimize resource allocation and patient outcomes. Learn more about the National Comprehensive Cancer Network (NCCN) guidelines for breast cancer follow-up care for specific recommendations based on individual patient characteristics.
Q: How can clinicians effectively address the psychosocial impact of breast cancer history on patients, including anxiety, fear of recurrence, and long-term effects of treatment like chemotherapy-induced neuropathy?
A: Addressing the psychosocial needs of patients with a breast cancer history is essential for their overall well-being. Many patients experience anxiety, fear of recurrence, and other psychological challenges. Validating patient concerns and providing open communication about their fears is the first step. Consider implementing screening tools, such as the Hospital Anxiety and Depression Scale (HADS) or the Distress Thermometer, to identify patients requiring additional support. Referral to mental health professionals specializing in oncology can provide evidence-based interventions like cognitive behavioral therapy (CBT) and mindfulness-based stress reduction. Explore how support groups and patient advocacy organizations can connect patients with peers and provide valuable resources. For managing long-term treatment side effects, like chemotherapy-induced neuropathy, consider referring patients to specialized clinics for pain management and rehabilitation.
Patient presents for routine surveillance following a history of breast cancer, now in remission. The patient's initial diagnosis of invasive ductal carcinoma, stage [Specify Stage - e.g., IIA], was confirmed by core needle biopsy in [Date of Original Diagnosis]. She subsequently underwent a [Surgical Procedure - e.g., lumpectomy with sentinel lymph node biopsy] followed by [Adjuvant Therapy - e.g., radiation therapy and chemotherapy with docetaxel and cyclophosphamide]. The patient completed active treatment on [Date of Treatment Completion]. Current clinical status indicates no evidence of disease recurrence. Physical examination reveals a well-healed surgical scar with no palpable masses, lymphadenopathy, or skin changes. Patient reports no new breast-related symptoms such as pain, nipple discharge, or skin dimpling. Mammography performed on [Date of Mammogram] demonstrated [Mammogram Findings - e.g., stable post-surgical changes, no suspicious masses]. Assessment: Breast cancer in remission, post-treatment surveillance. Plan: Continue routine breast cancer surveillance including annual mammograms and physical examinations. Patient education provided regarding breast self-awareness and the importance of follow-up care. Discussed potential long-term effects of breast cancer treatment and management options. Patient demonstrates understanding of her condition and the recommended surveillance plan. ICD-10 code Z85.3 (Personal history of malignant neoplasm of breast) is appropriate for this encounter.